Growth Metrics

Avai Bio (AVAI) Return on Capital Employed (2019 - 2025)

Avai Bio's Return on Capital Employed history spans 5 years, with the latest figure at 143.63% for Q1 2024.

  • On a quarterly basis, Return on Capital Employed rose 497.0% to 143.63% in Q1 2024 year-over-year; TTM through Mar 2024 was 143.63%, a 497.0% increase, with the full-year FY2024 number at 141.25%, down 1975.0% from a year prior.
  • Return on Capital Employed hit 143.63% in Q1 2024 for Avai Bio, up from 53.26% in the prior quarter.
  • Over the last five years, Return on Capital Employed for AVAI hit a ceiling of 1378.22% in Q2 2020 and a floor of 125.08% in Q4 2022.
  • Historically, Return on Capital Employed has averaged 149.06% across 4 years, with a median of 40.31% in 2020.
  • The widest YoY moves for Return on Capital Employed: up 134195bps in 2020, down 469bps in 2020.
  • Tracing AVAI's Return on Capital Employed over 4 years: stood at 34.49% in 2020, then tumbled by -463bps to 125.08% in 2022, then soared by 57bps to 53.26% in 2023, then surged by 370bps to 143.63% in 2024.
  • Business Quant data shows Return on Capital Employed for AVAI at 143.63% in Q1 2024, 53.26% in Q4 2023, and 15.23% in Q3 2023.